Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Impact of HLA Allele Mismatch at HLA-A, -B, -C, and -DRB1 in Single Cord Blood Transplantation.

Yokoyama H, Morishima Y, Fuji S, Uchida N, Takahashi S, Onizuka M, Tanaka M, Yuju O, Eto T, Ozawa Y, Takada S, Takanashi M, Kato K, Kanda Y, Ichinohe T, Atsuta Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 Nov 9. pii: S1083-8791(19)30741-4. doi: 10.1016/j.bbmt.2019.11.001. [Epub ahead of print]

PMID:
31715305
2.

Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-matched Allogeneic Transplantation: A Japanese National Registry Study.

Arima N, Kanda J, Yabe T, Morishima Y, Tanaka J, Kako S, Sakaguchi H, Kato M, Ohashi K, Ozawa Y, Fukuda T, Ota S, Tachibana T, Onizuka M, Ichinohe T, Atsuta Y, Kanda Y.

Biol Blood Marrow Transplant. 2019 Nov 5. pii: S1083-8791(19)30714-1. doi: 10.1016/j.bbmt.2019.10.032. [Epub ahead of print]

PMID:
31704471
3.

Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.

Ikeda T, Mori K, Kawamura K, Mori T, Hagiwara S, Ueda Y, Kahata K, Uchida N, Tsukada N, Murakami S, Yamamoto M, Takahashi T, Ichinohe T, Onizuka M, Atsuta Y, Kanda Y, Okamoto S, Sunami K, Takamatsu H.

Hematol Oncol. 2019 Oct 31. doi: 10.1002/hon.2688. [Epub ahead of print]

PMID:
31674032
4.

Effects of Haplotype Matching on Outcomes after Adult Single-Cord Blood Transplantation.

Kanda J, Kawase T, Tanaka H, Kojima H, Morishima Y, Uchida N, Nagafuji K, Matsuhashi Y, Ohta T, Onizuka M, Sakura T, Takahashi S, Miyakoshi S, Kobayashi H, Eto T, Tanaka J, Ichinohe T, Atsuta Y, Morishima S; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 Oct 9. pii: S1083-8791(19)30655-X. doi: 10.1016/j.bbmt.2019.09.035. [Epub ahead of print]

PMID:
31605821
5.

Impact of pretransplant donor-specific anti-HLA antibodies on cord blood transplantation on behalf of the Transplant Complications Working Group of Japan Society for Hematopoietic Cell Transplantation.

Fuji S, Oshima K, Ohashi K, Sawa M, Saito T, Eto T, Tanaka M, Onizuka M, Nakamae H, Shiratori S, Ozawa Y, Hidaka M, Nagamura-Inoue T, Tanaka H, Fukuda T, Ichinohe T, Atsuta Y, Ogata M.

Bone Marrow Transplant. 2019 Oct 7. doi: 10.1038/s41409-019-0712-0. [Epub ahead of print]

PMID:
31591450
6.

Conditioning Intensity for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Poor-Prognosis Cytogenetics in First Complete Remission.

Konuma T, Kondo T, Mizuno S, Doki N, Aoki J, Fukuda T, Tanaka M, Sawa M, Katayama Y, Uchida N, Ozawa Y, Morishige S, Matsuoka KI, Ichinohe T, Onizuka M, Kanda J, Atsuta Y, Yanada M; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 Sep 25. pii: S1083-8791(19)30636-6. doi: 10.1016/j.bbmt.2019.09.025. [Epub ahead of print]

PMID:
31562960
7.

Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning.

Terakura S, Onizuka M, Fukumoto M, Kuwatsuka Y, Kohno A, Ozawa Y, Miyamura K, Inagaki Y, Sawa M, Atsuta Y, Suzuki R, Naoe T, Morishita Y, Murata M; Nagoya Blood and Marrow Transplantation Group.

Int J Hematol. 2019 Sep 25. doi: 10.1007/s12185-019-02741-8. [Epub ahead of print]

PMID:
31555969
8.

Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis.

Tachibana T, Ishizaki T, Takahashi S, Najima Y, Kimura SI, Sakaida E, Onizuka M, Mori T, Fujisawa S, Fujiwara SI, Saito T, Hagihara M, Aotsuka N, Gotoh M, Usuki K, Tsukada N, Kanda J, Kanamori H, Kanda Y, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT).

Bone Marrow Transplant. 2019 Sep 19. doi: 10.1038/s41409-019-0689-8. [Epub ahead of print] No abstract available.

PMID:
31537900
9.

A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort.

Ohwada C, Sakaida E, Igarashi A, Kobayashi T, Doki N, Mori T, Kato J, Koda Y, Kanamori H, Tanaka M, Tachibana T, Fujisawa S, Nakajima Y, Numata A, Toyosaki M, Aoyama Y, Onizuka M, Hagihara M, Koyama S, Kanda Y, Nakasone H, Shimizu H, Kato S, Watanabe R, Shono K, Sakai R, Saito T, Nakaseko C, Okamoto S.

Biol Blood Marrow Transplant. 2019 Sep 16. pii: S1083-8791(19)30627-5. doi: 10.1016/j.bbmt.2019.09.016. [Epub ahead of print]

PMID:
31536824
10.

Impact of Homozygous Conserved Extended HLA Haplotype on Single Cord Blood Transplantation: Lessons for Induced Pluripotent Stem Cell Banking and Transplantation in Allogeneic Settings.

Morishima Y, Morishima S, Murata M, Arima N, Uchida N, Sugio Y, Takahashi S, Matsuhashi Y, Onizuka M, Eto T, Nagafuji K, Onishi Y, Inoue M, Atsuta Y, Fukuda T, Ichinohe T, Kato S, Kanda J.

Biol Blood Marrow Transplant. 2019 Sep 12. pii: S1083-8791(19)30595-6. doi: 10.1016/j.bbmt.2019.09.009. [Epub ahead of print]

PMID:
31521817
11.

Different impact of BCR-ABL transcripts on allogeneic hematopoietic cell transplantation from different graft sources for Ph + ALL with minimal residual disease.

Nishiwaki S, Mizuta S, Ohashi K, Fukuda T, Uchida N, Tachibana T, Onizuka M, Ozawa Y, Onishi Y, Takahashi S, Eto T, Nakamae H, Tanaka J, Ichinohe T, Atsuta Y, Kako S; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2019 Nov;94(11):E301-E305. doi: 10.1002/ajh.25612. Epub 2019 Aug 26. No abstract available.

PMID:
31403213
12.

Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia.

Akahoshi Y, Nishiwaki S, Mizuta S, Ohashi K, Uchida N, Tanaka M, Fukuda T, Ozawa Y, Takahashi S, Onizuka M, Shiratori S, Nakamae H, Kanda Y, Ichinohe T, Atsuta Y, Kako S; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Cancer Sci. 2019 Oct;110(10):3255-3266. doi: 10.1111/cas.14167. Epub 2019 Aug 29.

13.

The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation.

Harada K, Tachibana T, Ohashi K, Ozawa Y, Sawa M, Kondo T, Ishikawa J, Onizuka M, Imada K, Fujisaki T, Tanaka J, Fukuda T, Atsuta Y, Kako S.

Leuk Lymphoma. 2019 Jul 10:1-8. doi: 10.1080/10428194.2019.1636986. [Epub ahead of print]

PMID:
31290354
14.

[Progress in genomic analysis of the human leukocyte antigen].

Onizuka M.

Rinsho Ketsueki. 2019;60(6):620-625. doi: 10.11406/rinketsu.60.620. Review. Japanese.

PMID:
31281154
15.

Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation: on behalf of the Adult Lymphoma Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT).

Kato H, Kato K, Kim SW, Fukuda T, Mori T, Sawa M, Ohno Y, Yoshioka S, Iwato Y, Taji H, Onizuka M, Kurahashi S, Ichinohe T, Suzumiya J, Suzuki R.

Br J Haematol. 2019 Sep;186(6):e170-e175. doi: 10.1111/bjh.16050. Epub 2019 Jun 17. No abstract available.

PMID:
31206602
16.

Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis.

Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Matsumoto K, Aotsuka N, Goto M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S; Kanto Study; Group for Cell Therapy (KSGCT).

Leukemia. 2019 Nov;33(11):2610-2618. doi: 10.1038/s41375-019-0494-9. Epub 2019 May 30.

PMID:
31147621
17.

Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation.

Shimizu R, Takeuchi M, Sakaida E, Ohwada C, Toyosaki M, Machida S, Onizuka M, Shono K, Onoda M, Saito T, Yano S, Tanaka M, Fujisawa S, Mori T, Usuki K, Takahashi S, Kanamori H, Nakaseko C, Okamoto S.

Ann Hematol. 2019 Jul;98(7):1781-1783. doi: 10.1007/s00277-019-03717-8. Epub 2019 May 22. No abstract available.

PMID:
31119366
18.

Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Harada K, Konuma T, Machida S, Mori J, Aoki J, Uchida N, Ohashi K, Fukuda T, Tanaka M, Ikegame K, Ozawa Y, Iwato K, Eto T, Onizuka M, Ichinohe T, Atsuta Y, Yano S.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1730-1743. doi: 10.1016/j.bbmt.2019.04.025. Epub 2019 May 2.

PMID:
31054982
19.

A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma.

Kawai H, Matsushita H, Kawakami S, Furuya D, Shiraiwa-Hara S, Ichiki A, Hara R, Aoyama Y, Ogiya D, Suzuki R, Machida S, Onizuka M, Shirasugi Y, Ogawa Y, Kawada H, Nakamura N, Ando K.

J Clin Exp Hematop. 2019;59(1):34-39. doi: 10.3960/jslrt.18038.

20.

Graft-versus-MDS effect after unrelated cord blood transplantation: a retrospective analysis of 752 patients registered at the Japanese Data Center for Hematopoietic Cell Transplantation.

Ishiyama K, Aoki J, Itonaga H, Uchida N, Takahashi S, Ohno Y, Matsuhashi Y, Sakura T, Onizuka M, Miyakoshi S, Takanashi M, Fukuda T, Atsuta Y, Nakao S, Miyazaki Y.

Blood Cancer J. 2019 Mar 6;9(3):31. doi: 10.1038/s41408-019-0192-x.

21.

Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation.

Fujiwara SI, Kanda J, Tatara R, Ogawa H, Fukuda T, Okumura H, Ohashi K, Iwato K, Ueda Y, Ishiyama K, Eto T, Matsuoka KI, Nakamae H, Onizuka M, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Aug;54(8):1327-1336. doi: 10.1038/s41409-019-0434-3. Epub 2019 Jan 22.

PMID:
30670824
22.

Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy.

Nomoto H, Takami A, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Morishita E.

Int J Mol Sci. 2019 Jan 8;20(1). pii: E214. doi: 10.3390/ijms20010214.

23.

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome.

Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Fukuda T, Onizuka M, Eto T, Ota S, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Haematologica. 2019 May;104(5):1055-1061. doi: 10.3324/haematol.2018.204438. Epub 2018 Dec 6.

24.

Iron removal enhances vitamin C-induced apoptosis and growth inhibition of K-562 leukemic cells.

Tsuma-Kaneko M, Sawanobori M, Kawakami S, Uno T, Nakamura Y, Onizuka M, Ando K, Kawada H.

Sci Rep. 2018 Nov 26;8(1):17377. doi: 10.1038/s41598-018-35730-8.

25.

Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning.

Harada K, Yanada M, Machida S, Kanamori H, Onizuka M, Ozawa Y, Kobayashi H, Sawa M, Katayama Y, Ohashi K, Kanda J, Ichinohe T, Atsuta Y, Yano S.

Leuk Lymphoma. 2019 Jun;60(6):1493-1502. doi: 10.1080/10428194.2018.1535115. Epub 2018 Nov 20.

PMID:
30457400
26.

Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation.

Yokoyama H, Kanda J, Kato S, Kondo E, Maeda Y, Saji H, Takahashi S, Onizuka M, Onishi Y, Ozawa Y, Kanamori H, Ishikawa J, Ohno Y, Ichinohe T, Takanashi M, Kato K, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Jul;54(7):1004-1012. doi: 10.1038/s41409-018-0369-0. Epub 2018 Nov 6.

PMID:
30401965
27.

Upfront allogeneic hematopoietic cell transplantation (HCT) versus remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: A propensity score matched analysis.

Konuma T, Harada K, Yamasaki S, Mizuno S, Uchida N, Takahashi S, Onizuka M, Nakamae H, Hidaka M, Fukuda T, Ohashi K, Kohno A, Matsushita A, Kanamori H, Ashida T, Kanda J, Atsuta Y, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2019 Jan;94(1):103-110. doi: 10.1002/ajh.25336. Epub 2018 Nov 29.

PMID:
30370944
28.

Induction chemotherapy followed by allogeneic HCT versus upfront allogeneic HCT for advanced myelodysplastic syndrome: A propensity score matched analysis.

Konuma T, Shimomura Y, Ozawa Y, Ueda Y, Uchida N, Onizuka M, Akiyama M, Mori T, Nakamae H, Ohno Y, Shiratori S, Onishi Y, Kanda Y, Fukuda T, Atsuta Y, Ishiyama K; Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Hematol Oncol. 2019 Feb;37(1):85-95. doi: 10.1002/hon.2566. Epub 2018 Nov 19.

PMID:
30370627
29.

Comparison of HLA Allele Mismatch and Antigen Mismatch in Unrelated Bone Marrow Transplantation in Patients with Leukemia.

Atsuta Y, Kato S, Morishima Y, Ohashi K, Fukuda T, Ozawa Y, Eto T, Iwato K, Uchida N, Ota S, Onizuka M, Ichinohe T, Kanda J, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 Mar;25(3):436-442. doi: 10.1016/j.bbmt.2018.10.002. Epub 2018 Oct 8.

PMID:
30308326
30.

[Current management of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].

Onizuka M.

Rinsho Ketsueki. 2018;59(10):2028-2035. doi: 10.11406/rinketsu.59.2028. Review. Japanese.

PMID:
30305505
31.

Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey.

Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Fujisawa S, Onishi Y, Yano S, Onizuka M, Kanda Y, Mizuno I, Taniguchi S, Yamashita T, Inamoto Y, Okamoto S, Atsuta Y.

Bone Marrow Transplant. 2019 Apr;54(4):611-615. doi: 10.1038/s41409-018-0343-x. Epub 2018 Oct 4. No abstract available.

PMID:
30287939
32.

Correction to: Dysplastic features seen in a patient with acute myeloid leukemia harboring the KMT2A-TET1 fusion gene.

Kawai H, Matsushita H, Aoyama Y, Matsui K, Onizuka M, Ando K.

Int J Hematol. 2018 Aug;108(2):232. doi: 10.1007/s12185-018-2476-5.

PMID:
29948955
33.

Additional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era.

Akahoshi Y, Mizuta S, Shimizu H, Uchida N, Fukuda T, Kanamori H, Onizuka M, Ozawa Y, Ohashi K, Ohta S, Eto T, Tanaka J, Atsuta Y, Kako S; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2009-2016. doi: 10.1016/j.bbmt.2018.06.006. Epub 2018 Jun 14.

34.

Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells?

Nakasone H, Tabuchi K, Uchida N, Ohno Y, Matsuhashi Y, Takahashi S, Onishi Y, Onizuka M, Kobayashi H, Fukuda T, Ichinohe T, Takanashi M, Kato K, Atsuta Y, Yabe H, Kanda Y.

Br J Haematol. 2019 Apr;185(1):166-169. doi: 10.1111/bjh.15418. Epub 2018 May 29. No abstract available.

PMID:
29808925
35.

Dysplastic features seen in a patient with acute myeloid leukemia harboring the KTM2A-TET1 fusion gene.

Kawai H, Matsushita H, Aoyama Y, Matsui K, Onizuka M, Ando K.

Int J Hematol. 2018 Jul;108(1):1-2. doi: 10.1007/s12185-018-2469-4. Epub 2018 May 9. No abstract available. Erratum in: Int J Hematol. 2018 Aug;108(2):232.

PMID:
29744807
36.

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study.

Harada Y, Nagata Y, Kihara R, Ishikawa Y, Asou N, Ohtake S, Miyawaki S, Sakura T, Ozawa Y, Usui N, Kanamori H, Ito Y, Imai K, Suehiro Y, Kobayashi S, Kitamura K, Sakaida E, Onizuka M, Takeshita A, Ishida F, Suzushima H, Ishizawa K, Naoe T, Matsumura I, Miyazaki Y, Ogawa S, Kiyoi H; Japan Adult Leukemia Study Group JALSG.

Leuk Res. 2018 Mar;66:20-27. doi: 10.1016/j.leukres.2018.01.008. Epub 2018 Jan 17.

PMID:
29360622
37.

[Impact of genetic polymorphisms on post-transplant complications].

Onizuka M.

Rinsho Ketsueki. 2017;58(12):2432-2439. doi: 10.11406/rinketsu.58.2432. Japanese.

PMID:
29332880
38.

Clinicopathological Analysis of 320 Cases of Diffuse Large B-cell Lymphoma Using the Hans Classifier.

Ichiki A, Carreras J, Miyaoka M, Kikuti YY, Jibiki T, Tazume K, Watanabe S, Sasao T, Obayashi Y, Onizuka M, Ohmachi K, Yoshiba F, Shirasugi Y, Ogawa Y, Kawada H, Nakamura N, Ando K.

J Clin Exp Hematop. 2017;57(2):54-63. doi: 10.3960/jslrt.17029.

39.

Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults.

Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Hidaka M, Kobayashi N, Iwato K, Sakura T, Onizuka M, Ozawa Y, Eto T, Kurokawa M, Kahata K, Uchida N, Atsuta Y, Mizuta S, Kako S.

Am J Hematol. 2018 Jan;93(1):47-57. doi: 10.1002/ajh.24933. Epub 2017 Nov 9.

40.

NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.

Hara R, Onizuka M, Matsusita E, Kikkawa E, Nakamura Y, Matsushita H, Ohgiya D, Murayama H, Machida S, Ohmachi K, Shirasugi Y, Ogawa Y, Kawada H, Ando K.

Int J Hematol. 2017 Nov;106(5):666-674. doi: 10.1007/s12185-017-2294-1. Epub 2017 Aug 9.

PMID:
28795321
41.

Factors affecting the interaction between carbon nanotubes and redox enzymes in direct electron transfer-type bioelectrocatalysis.

Xia HQ, Kitazumi Y, Shirai O, Ozawa H, Onizuka M, Komukai T, Kano K.

Bioelectrochemistry. 2017 Dec;118:70-74. doi: 10.1016/j.bioelechem.2017.07.003. Epub 2017 Jul 13.

PMID:
28732287
42.

GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia.

Terakura S, Kuwatsuka Y, Yamasaki S, Wake A, Kanda J, Inamoto Y, Mizuta S, Yamaguchi T, Uchida N, Kouzai Y, Aotsuka N, Ogawa H, Kanamori H, Nishiwaki K, Miyakoshi S, Onizuka M, Amano I, Fukuda T, Ichinohe T, Atsuta Y, Murata M, Teshima T.

Bone Marrow Transplant. 2017 Sep;52(9):1261-1267. doi: 10.1038/bmt.2017.116. Epub 2017 Jun 12.

PMID:
28604665
43.

Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia.

Kondo T, Nagamura-Inoue T, Tojo A, Nagamura F, Uchida N, Nakamae H, Fukuda T, Mori T, Yano S, Kurokawa M, Ueno H, Kanamori H, Hashimoto H, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Ohashi K.

Am J Hematol. 2017 Sep;92(9):902-908. doi: 10.1002/ajh.24793. Epub 2017 Jun 9.

44.

Comparison of Autologous and Unrelated Transplants for Cytogenetically Normal Acute Myelogenous Leukemia.

Mizutani M, Takami A, Hara M, Mizuno S, Yanada M, Chou T, Uchiyama H, Ohashi K, Miyamoto T, Ozawa Y, Imataki O, Kobayashi N, Uchida N, Kanamori H, Kamimura T, Eto T, Onizuka M, Tanaka J, Atsuta Y, Yano S.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1447-1454. doi: 10.1016/j.bbmt.2017.05.008. Epub 2017 May 19.

45.

The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation.

Horio T, Mizuno S, Uchino K, Mizutani M, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Takami A.

Transpl Immunol. 2017 Jun;42:34-39. doi: 10.1016/j.trim.2017.05.003. Epub 2017 May 6.

PMID:
28487238
46.

Toll-like receptor genetic variations in bone marrow transplantation.

Uchino K, Mizuno S, Sato-Otsubo A, Nannya Y, Mizutani M, Horio T, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Ogawa S, Takami A.

Oncotarget. 2017 Jul 11;8(28):45670-45686. doi: 10.18632/oncotarget.17315.

47.

Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults.

Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Kawakita T, Mori T, Hoshino T, Onizuka M, Ozawa Y, Yoshida S, Ueda Y, Mizuno I, Atsuta Y, Mizuta S; Japan Society for Haematopoietic Cell Transplantation.

Br J Haematol. 2017 Jul;178(1):106-111. doi: 10.1111/bjh.14652. Epub 2017 Apr 25.

PMID:
28439877
48.

Cortical cells reveal APP as a new player in the regulation of GABAergic neurotransmission.

Doshina A, Gourgue F, Onizuka M, Opsomer R, Wang P, Ando K, Tasiaux B, Dewachter I, Kienlen-Campard P, Brion JP, Gailly P, Octave JN, Pierrot N.

Sci Rep. 2017 Mar 23;7(1):370. doi: 10.1038/s41598-017-00325-2.

49.

Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.

Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, Shiraishi Y, Suzuki H, Nagata Y, Sato Y, Kakiuchi N, Matsuo K, Onizuka M, Kataoka K, Chiba K, Tanaka H, Ueno H, Nakagawa MM, Przychodzen B, Haferlach C, Kern W, Aoki K, Itonaga H, Kanda Y, Sekeres MA, Maciejewski JP, Haferlach T, Miyazaki Y, Horibe K, Sanada M, Miyano S, Makishima H, Ogawa S.

Blood. 2017 Apr 27;129(17):2347-2358. doi: 10.1182/blood-2016-12-754796. Epub 2017 Feb 21.

50.

Successful treatment with low-dose nivolumab in refractory Hodgkin lymphoma after allogeneic stem cell transplantation.

Onizuka M, Kojima M, Matsui K, Machida S, Toyosaki M, Aoyama Y, Kawai H, Amaki J, Hara R, Ichiki A, Ogawa Y, Kawada H, Nakamura N, Ando K.

Int J Hematol. 2017 Jul;106(1):141-145. doi: 10.1007/s12185-017-2181-9. Epub 2017 Jan 17.

PMID:
28097534

Supplemental Content

Loading ...
Support Center